The Surging Demand For Non-Therapeutic Biomolecules In Research And Laboratory Testing Driving Market Acceleration in the Non-Therapeutic Biomolecules Industry, 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Non-Therapeutic Biomolecules Market Size By 2025?
The market share of non-therapeutic biomolecules has witnessed a swift expansion in the past few years. The market is estimated to advance from a valuation of $30.76 billion in 2024 to $33.92 billion in 2025, portraying a compound annual growth rate (CAGR) of 10.3%. Factors such as escalated investments in research and development (R&D), extended applications in research and diagnostics, heightened recognition and implementation, strategic associations and alliances, along with regulatory support, have contributed to the growth observed in the historic phase.

How Big Is the Non-Therapeutic Biomolecules Market Size Expected to Grow by 2029?
The market for non-therapeutic biomolecules is projected to experience a swift expansion in the coming years. With a compound annual growth rate (CAGR) of 10.8%, its size is expected to reach $51.03 billion by 2029. The growth predicted for this time frame can be tied to evolving market potentials, progressive developments in data integration and analytics, growing attention towards precision medicine, an upsurge in investment for personalized healthcare and broadening areas of application. Major anticipations for this forecast period include technological progression, strategic partnerships, increased agricultural applications, the wider role in industrial procedures, and an emphasis on customization and personalization.

View the full report here:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report

Which Key Market Drivers Powering Non-Therapeutic Biomolecules Market Expansion and Growth?
The non-therapeutic biomolecules market is anticipated to experience growth, driven by the fast-rising volume of research and laboratory tests. Laboratory testing encompasses a medical procedure that tests samples of body fluids like blood and urine to aid in disease detection and crafting of suitable treatment plans. Concurrently, research is associated with creating new knowledge or ingeniously using current knowledge to develop new concepts, theories, and understandings. Non-therapeutic biomolecules play a key role in these lab tests by quantifying the presence or level of a biomarker molecule that signifies disease, thus improving the test's sensitivity and specificity. For instance, the National Health Service (NHS), a healthcare provider based in the UK, reported in July 2024 that diagnostic activity surpassed the pre-pandemic levels in 2023, recording a 21% increase in the tests carried out in May 2024 compared to the previous year. Consequently, this escalating volume of research and laboratory tests is steering the growth of the non-therapeutic biomolecules market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8769&type=smp

What Are the Key Trends Driving Non-Therapeutic Biomolecules Market Growth?
There is an emerging trend in the non-therapeutic biomolecules market, where product innovation is gaining traction. To maintain their market relevance, leading companies are investing heavily in research and development geared towards innovative products. In a recent development in January 2022, BASF SE, a chemical firm based in Germany, partnered with Caregen, a Korean biomimetic peptide research and development company. Together, they launched the Peptovitae series, leveraging liposome-encapsulation technology to diversify its dermo-cosmetics portfolio. This technology enables the targeted delivery of vital vitamins or medicines via microscopic lipid bubbles, excluding other body parts from the impact. The newly introduced Peptovitae series offers solutions to a more extensive scope of skin-related issues than peptides traditionally do, such as signs of aging, skin brightness enhancement, the soothing of dry and itchy skin, as well as skin hydration.

What Are the Emerging Segments in the Non-Therapeutic Biomolecules Market?
The non-therapeutic biomolecules market covered in this report is segmented -

1) By Trad Pharma: Enzymes, Recombinant Proteins, Plasmids, Peptides, Oligonucleotides, Monoclonal Antibodies
2) By End User: Research, Pharma, In Vitro Diagnostics(IVD)

Subsegments:
1) By Enzymes: Industrial Enzymes, Diagnostic Enzymes
2) By Recombinant Proteins: Antigens, Cytokines, Growth Factors
3) By Plasmids: Research Plasmids, Expression Plasmids
4) By Peptides: Antimicrobial Peptides, Signaling Peptides
5) By Oligonucleotides: Antisense Oligonucleotides, RNAi Oligonucleotides
6) By Monoclonal Antibodies: Research Antibodies, Diagnostic Antibodies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=8769&type=smp

Who Are the Global Leaders in the Non-Therapeutic Biomolecules Market?
Major companies operating in the non-therapeutic biomolecules market are Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Synlogic Inc., 3M Company, Eppendorf AG, Medtronic Plc, Bio-Techne Corporation, Iovance Biotherapeutics Inc., Vectalys, Avid Bioservices Inc., Sientra Inc.

Which are the Top Profitable Regional Markets for the Non-Therapeutic Biomolecules Industry?
Asia-Pacific was the largest region in the non-therapeutic biomolecules market share in 2024. The regions covered in the non-therapeutic biomolecules market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8769

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.